fluprednisolone has been researched along with Cushing Syndrome in 2 studies
Fluprednisolone: A synthetic glucocorticoid with anti-inflammatory properties.
Cushing Syndrome: A condition caused by prolonged exposure to excess levels of cortisol (HYDROCORTISONE) or other GLUCOCORTICOIDS from endogenous or exogenous sources. It is characterized by upper body OBESITY; OSTEOPOROSIS; HYPERTENSION; DIABETES MELLITUS; HIRSUTISM; AMENORRHEA; and excess body fluid. Endogenous Cushing syndrome or spontaneous hypercortisolism is divided into two groups, those due to an excess of ADRENOCORTICOTROPIN and those that are ACTH-independent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Some difluprednate treated dogs developed mild to severe alopecia of the periocular region, face, and distal pinna (5/9)." | 5.62 | Localized alopecia and suppression of hypothalamic-pituitary-adrenal (HPA) axis in dogs following treatment with difluprednate 0.05% ophthalmic emulsion (Durezol®). ( Anderson, AL; Burn, JB; Del Valle, JM; Harman, CD; Komáromy, AM; Langlois, DK; Noland, EL; Occelli, LM; Petersen, AD; Petersen-Jones, SM; Pirie, CG; Quantz, K, 2021) |
| "Some difluprednate treated dogs developed mild to severe alopecia of the periocular region, face, and distal pinna (5/9)." | 1.62 | Localized alopecia and suppression of hypothalamic-pituitary-adrenal (HPA) axis in dogs following treatment with difluprednate 0.05% ophthalmic emulsion (Durezol®). ( Anderson, AL; Burn, JB; Del Valle, JM; Harman, CD; Komáromy, AM; Langlois, DK; Noland, EL; Occelli, LM; Petersen, AD; Petersen-Jones, SM; Pirie, CG; Quantz, K, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Quantz, K | 1 |
| Anderson, AL | 1 |
| Harman, CD | 1 |
| Noland, EL | 1 |
| Del Valle, JM | 1 |
| Occelli, LM | 1 |
| Burn, JB | 1 |
| Petersen-Jones, SM | 1 |
| Langlois, DK | 1 |
| Pirie, CG | 1 |
| Petersen, AD | 1 |
| Komáromy, AM | 1 |
| EXLEY, D | 1 |
| NORYMBERSKI, JK | 1 |
2 other studies available for fluprednisolone and Cushing Syndrome
| Article | Year |
|---|---|
Localized alopecia and suppression of hypothalamic-pituitary-adrenal (HPA) axis in dogs following treatment with difluprednate 0.05% ophthalmic emulsion (Durezol®).
Topics: Adrenocorticotropic Hormone; Alopecia; Animals; Cushing Syndrome; Dog Diseases; Dogs; Emulsions; Fem | 2021 |
URINARY EXCRETION OF 17-DEOXYCORTICOSTEROIDS BY MAN.
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Addison Disease; Adrenal Insufficiency; Aging; Cushing S | 1964 |